Aotearoa New Zealand had a vaping prevalence of 1.4% in 2015/2016[xxiii] - this was in contrast to the UK, which in 2016 had a legal vape market and a vaping prevalence four times that of Aotearoa New Zealand at 5.7%.[xxiv] Following legalisation of nicotine-containing vaping products in 2018, Aotearoa New Zealand experienced a rapid uptake of vaping, to the extent that vaping product use has, as of 2022, overtaken tobacco smoking in Aotearoa New Zealand, according to the latest data from the New Zealand Health Survey.[xxv] Shortly after the legalisation of nicotine vaping products in Aotearoa New Zealand, a 2019 survey of current and former smokers in 14 countries,[xxvi] including the USA, Australia and China, found that Aotearoa New Zealand had the second highest prevalence of vaping among ex-and-current- smokers, second only to the United Kingdom
You Asked: What Are My Hiccups Telling Me
Tobacco is, and continues to be, a threat
Conclusions In our case series of 16 patients, predominantly male, diagnosed with EVALI there was a high incidence of gastrointestinal symptoms on presentation and follow up pulmonary function tests suggested there may be an increased risk for obstructive lung disease
Most individuals compensate with larger or more frequent hits to achieve a similar level of nicotine, carving most variations
Crop Sci 27:12191224 Davis RE (1976) A combined automated procedure for the determination of reducing sugars and nicotine alkaloids in tobacco products using a new reducing sugar method
